• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NTI

NEUROTECH INTERNATIONAL LIMITED - Announcements

7.69% ! 1.4¢
Market Cap $14.69M  !

Neurotech International Limited is an Australia-based clinical-stage biopharmaceutical... Neurotech International Limited is an Australia-based clinical-stage biopharmaceutical development company. The Company is focused predominately on pediatric neurological disorders with a broad-spectrum oral cannabinoid drug therapy called NTI164. It has completed a Phase II/III randomized, double-blind, placebo-controlled clinical trial in autism spectrum disorder (ASD) with clinically significant benefits reported across a number of clinically validated measures and safety. In addition, it has completed and reported significant and clinically meaningful Phase I/II trials in ASD and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS), collectively PANDAS/PANS along with Rett Syndrome. NTI164 is being developed as a therapeutic drug product for a range of neurological disorders in children where neuroinflammation is involved.More

Announcements



NTI Appendix 3B29/01/19 download Created with Sketch. 490.22KB
NTI Prospectus - Renounceable Rights IssuePRICE SENSITIVE29/01/19 download Created with Sketch. 398.28KB
NTI Investor Presentation - Amended29/01/19 download Created with Sketch. 1.26MB
NTI Investor PresentationPRICE SENSITIVE29/01/19 download Created with Sketch. 1.06MB
NTI Neurotech Rights IssuePRICE SENSITIVE29/01/19 download Created with Sketch. 227.03KB
NTI New Direction for US Market21/12/18 download Created with Sketch. 182.78KB
NTI Return of Founder as Strategic Advisor20/12/18 download Created with Sketch. 169.82KB
NTI Appendix 3Y - D Cantor04/12/18 download Created with Sketch. 216.43KB
NTI Appendix 3B04/12/18 download Created with Sketch. 427.62KB
NTI Clarification - Results of Annual General Meeting30/11/18 download Created with Sketch. 138.69KB
NTI Appendix 3Z - C Tan30/11/18 download Created with Sketch. 184.42KB
NTI Results of Annual General Meeting30/11/18 download Created with Sketch. 135.79KB
NTI Chairman's Address, 2018 Annual General Meeting30/11/18 download Created with Sketch. 229.81KB
NTI Appendix 3Z - W Storf26/11/18 download Created with Sketch. 189.73KB
NTI Appointment of Peter Griffiths as CEOPRICE SENSITIVE26/11/18 download Created with Sketch. 158.62KB
NTI Appenxidx 3B16/11/18 download Created with Sketch. 350.19KB
NTI Mente presentation at International Congress on Autism13/11/18 download Created with Sketch. 201.37KB
NTI Change in substantial holding12/11/18 download Created with Sketch. 703.46KB
NTI AGM Notice of Meeting - Despatch31/10/18 download Created with Sketch. 531.48KB
NTI New AppointmentsPRICE SENSITIVE23/10/18 download Created with Sketch. 189.26KB
NTI Quarterly reportPRICE SENSITIVE19/10/18 download Created with Sketch. 2.87MB
NTI Change of Address08/10/18 download Created with Sketch. 172.41KB
NTI Initial Director's Interest Notice04/10/18 download Created with Sketch. 206.29KB
NTI Shipment of Mente Autism devicesPRICE SENSITIVE04/10/18 download Created with Sketch. 219.17KB
NTI Appointment of Dr Neale Fong to the Board03/10/18 download Created with Sketch. 166.36KB
NTI Mente Autism - FDA Clearance ApplicationPRICE SENSITIVE02/10/18 download Created with Sketch. 169.98KB
NTI Appendix 4E and Annual ReportPRICE SENSITIVE03/09/18 download Created with Sketch. 945.04KB
NTI Appendix 4G31/08/18 download Created with Sketch. 287.67KB
NTI Corporate Governance Statement31/08/18 download Created with Sketch. 427.82KB
NTI Change in substantial holding20/08/18 download Created with Sketch. 220.42KB
NTI Investor Presentation13/08/18 download Created with Sketch. 1.99MB
NTI First Shipments of Mente AutismPRICE SENSITIVE10/08/18 download Created with Sketch. 186.77KB
NTI Quarterly report and Appendix 4CPRICE SENSITIVE31/07/18 download Created with Sketch. 427.62KB
NTI US Clinical Trial / Investor Webinar12/07/18 download Created with Sketch. 3.06MB
NTI Webinar Presentation12/07/18 download Created with Sketch. 2.78MB
NTI Investor Webinar10/07/18 download Created with Sketch. 169.43KB
NTI US Clinical Trial Results PublishedPRICE SENSITIVE09/07/18 download Created with Sketch. 1.73MB
NTI Initial Director's Interest Notice06/07/18 download Created with Sketch. 174.43KB
NTI Trading HaltPRICE SENSITIVE05/07/18 download Created with Sketch. 352.7KB
NTI Neuroscience expert Dr David Cantor appointed to the board04/07/18 download Created with Sketch. 169.94KB
NTI Final Director's Interest Notice28/06/18 download Created with Sketch. 185.93KB
NTI Board Change28/06/18 download Created with Sketch. 161.94KB
NTI Change in substantial holding27/06/18 download Created with Sketch. 145.62KB
NTI Clinical Trial Publication Provisionally Accepted25/06/18 download Created with Sketch. 333.85KB
NTI Mente Autism Approval From ItalcertPRICE SENSITIVE04/06/18 download Created with Sketch. 169.99KB
NTI Appendix 3B14/05/18 download Created with Sketch. 249.25KB
NTI Quarterly Report and Appendix 4CPRICE SENSITIVE30/04/18 download Created with Sketch. 370.77KB
NTI Appendix 4D and 31 December 2017 Half Year Financial ReportPRICE SENSITIVE28/02/18 download Created with Sketch. 439.78KB
NTI Amendment to December 2017 Quarterly Report05/02/18 download Created with Sketch. 777.66KB
NTI Quarterly Report and Appendix 4CPRICE SENSITIVE30/01/18 download Created with Sketch. 783.6KB
NTI Change in substantial holding22/01/18 download Created with Sketch. 129.76KB
NTI Indian Distribution AgreementPRICE SENSITIVE18/01/18 download Created with Sketch. 582.09KB
NTI Clarification Statement10/01/18 download Created with Sketch. 572.86KB
NTI Becoming a substantial holder10/01/18 download Created with Sketch. 146.57KB
NTI Clinical Trial Update08/01/18 download Created with Sketch. 593.49KB
NTI Change of Directors Interest Notice30/11/17 download Created with Sketch. 364.02KB
NTI Change of Directors Interest Notice30/11/17 download Created with Sketch. 363.65KB
NTI Appendix 3B30/11/17 download Created with Sketch. 704.07KB
NTI Design Agreement with eemaginePRICE SENSITIVE27/11/17 download Created with Sketch. 578.27KB
NTI 2017 AGM Results23/11/17 download Created with Sketch. 374.75KB
NTI AGM Presentation23/11/17 download Created with Sketch. 1.95MB
NTI Investor Call09/11/17 download Created with Sketch. 583.01KB
NTI Quarterly Report and Appendix 4CPRICE SENSITIVE31/10/17 download Created with Sketch. 906.16KB
NTI Announcement Correction25/10/17 download Created with Sketch. 476.75KB
NTI Appendix 3B25/10/17 download Created with Sketch. 688.97KB
NTI Allotment of Placement Shares25/10/17 download Created with Sketch. 483.42KB
NTI Notice of Meeting - Despatch23/10/17 download Created with Sketch. 1.56MB
NTI Reinstatement to Official QuotationPRICE SENSITIVE16/10/17 download Created with Sketch. 251.67KB
NTI Capital Raising CompletedPRICE SENSITIVE16/10/17 download Created with Sketch. 595.56KB
NTI Suspension from Official QuotationPRICE SENSITIVE12/10/17 download Created with Sketch. 559.91KB
NTI Trading HaltPRICE SENSITIVE11/10/17 download Created with Sketch. 764.02KB
NTI Neurotech Investor Presentation04/10/17 download Created with Sketch. 3.03MB
NTI Response to ASX QueryPRICE SENSITIVE03/10/17 download Created with Sketch. 916.91KB
NTI Neurotech Presentations28/09/17 download Created with Sketch. 596.79KB
NTI Clinical Trial Preliminary OutcomesPRICE SENSITIVE27/09/17 download Created with Sketch. 619.33KB
NTI Trading HaltPRICE SENSITIVE25/09/17 download Created with Sketch. 531.65KB
NTI Distributor UpdatePRICE SENSITIVE14/09/17 download Created with Sketch. 604.91KB
NTI Corporate Governance Statement06/09/17 download Created with Sketch. 379.16KB
NTI Appendix 4EPRICE SENSITIVE01/09/17 download Created with Sketch. 365.03KB
NTI Annual Report to shareholders31/08/17 download Created with Sketch. 955.11KB
NTI Appendix 4G31/08/17 download Created with Sketch. 378.22KB
NTI Italian Distributor UpdatePRICE SENSITIVE21/08/17 download Created with Sketch. 476.74KB
NTI Quarterly Report and Appendix 4CPRICE SENSITIVE31/07/17 download Created with Sketch. 794.83KB
NTI Neurotech completes Turkey shipmentPRICE SENSITIVE10/07/17 download Created with Sketch. 638.08KB
NTI Neurotech renews Turkey distribution agreementPRICE SENSITIVE26/06/17
NTI Distribution UpdatePRICE SENSITIVE19/06/17 download Created with Sketch. 498.83KB
NTI 2017 European Neuro Convention Presentation08/06/17 download Created with Sketch. 2.61MB
NTI Mente Autism UpdatePRICE SENSITIVE05/06/17 download Created with Sketch. 600.32KB
NTI US Clinical Trial UpdatePRICE SENSITIVE29/05/17 download Created with Sketch. 591.33KB
NTI First Shipment to GreecePRICE SENSITIVE25/05/17 download Created with Sketch. 600.17KB
NTI Distribution UpdatePRICE SENSITIVE22/05/17 download Created with Sketch. 583.41KB
NTI Appendix 3B and Release of Restricted Securities from Escrow15/05/17 download Created with Sketch. 268.43KB
NTI FDA UpdatePRICE SENSITIVE12/05/17 download Created with Sketch. 475.69KB
NTI Quarterly ReportsPRICE SENSITIVE26/04/17 download Created with Sketch. 2.78MB
NTI Distribution Partner UpdatePRICE SENSITIVE26/04/17 download Created with Sketch. 477.23KB
NTI Release of 699,000 Shares from Escrow21/04/17 download Created with Sketch. 342.03KB
NTI FDA Pre submission and World Autism Awareness DayPRICE SENSITIVE30/03/17 download Created with Sketch. 490.57KB
NTI US Clinical Trial UpdatePRICE SENSITIVE29/03/17 download Created with Sketch. 483KB
NTI Mente Pro UpdatePRICE SENSITIVE09/03/17 download Created with Sketch. 597.39KB
NTI Austrian Distribution PartnerPRICE SENSITIVE02/03/17 download Created with Sketch. 480.5KB
NTI Appendix 3B
29/01/19 download Created with Sketch. 490.22KB
NTI Prospectus - Renounceable Rights Issue
29/01/19PRICE SENSITIVE download Created with Sketch. 398.28KB
NTI Investor Presentation - Amended
29/01/19 download Created with Sketch. 1.26MB
NTI Investor Presentation
29/01/19PRICE SENSITIVE download Created with Sketch. 1.06MB
NTI Neurotech Rights Issue
29/01/19PRICE SENSITIVE download Created with Sketch. 227.03KB
NTI New Direction for US Market
21/12/18 download Created with Sketch. 182.78KB
NTI Return of Founder as Strategic Advisor
20/12/18 download Created with Sketch. 169.82KB
NTI Appendix 3Y - D Cantor
04/12/18 download Created with Sketch. 216.43KB
NTI Appendix 3B
04/12/18 download Created with Sketch. 427.62KB
NTI Clarification - Results of Annual General Meeting
30/11/18 download Created with Sketch. 138.69KB
NTI Appendix 3Z - C Tan
30/11/18 download Created with Sketch. 184.42KB
NTI Results of Annual General Meeting
30/11/18 download Created with Sketch. 135.79KB
NTI Chairman's Address, 2018 Annual General Meeting
30/11/18 download Created with Sketch. 229.81KB
NTI Appendix 3Z - W Storf
26/11/18 download Created with Sketch. 189.73KB
NTI Appointment of Peter Griffiths as CEO
26/11/18PRICE SENSITIVE download Created with Sketch. 158.62KB
NTI Appenxidx 3B
16/11/18 download Created with Sketch. 350.19KB
NTI Mente presentation at International Congress on Autism
13/11/18 download Created with Sketch. 201.37KB
NTI Change in substantial holding
12/11/18 download Created with Sketch. 703.46KB
NTI AGM Notice of Meeting - Despatch
31/10/18 download Created with Sketch. 531.48KB
NTI New Appointments
23/10/18PRICE SENSITIVE download Created with Sketch. 189.26KB
NTI Quarterly report
19/10/18PRICE SENSITIVE download Created with Sketch. 2.87MB
NTI Change of Address
08/10/18 download Created with Sketch. 172.41KB
NTI Initial Director's Interest Notice
04/10/18 download Created with Sketch. 206.29KB
NTI Shipment of Mente Autism devices
04/10/18PRICE SENSITIVE download Created with Sketch. 219.17KB
NTI Appointment of Dr Neale Fong to the Board
03/10/18 download Created with Sketch. 166.36KB
NTI Mente Autism - FDA Clearance Application
02/10/18PRICE SENSITIVE download Created with Sketch. 169.98KB
NTI Appendix 4E and Annual Report
03/09/18PRICE SENSITIVE download Created with Sketch. 945.04KB
NTI Appendix 4G
31/08/18 download Created with Sketch. 287.67KB
NTI Corporate Governance Statement
31/08/18 download Created with Sketch. 427.82KB
NTI Change in substantial holding
20/08/18 download Created with Sketch. 220.42KB
NTI Investor Presentation
13/08/18 download Created with Sketch. 1.99MB
NTI First Shipments of Mente Autism
10/08/18PRICE SENSITIVE download Created with Sketch. 186.77KB
NTI Quarterly report and Appendix 4C
31/07/18PRICE SENSITIVE download Created with Sketch. 427.62KB
NTI US Clinical Trial / Investor Webinar
12/07/18 download Created with Sketch. 3.06MB
NTI Webinar Presentation
12/07/18 download Created with Sketch. 2.78MB
NTI Investor Webinar
10/07/18 download Created with Sketch. 169.43KB
NTI US Clinical Trial Results Published
09/07/18PRICE SENSITIVE download Created with Sketch. 1.73MB
NTI Initial Director's Interest Notice
06/07/18 download Created with Sketch. 174.43KB
NTI Trading Halt
05/07/18PRICE SENSITIVE download Created with Sketch. 352.7KB
NTI Neuroscience expert Dr David Cantor appointed to the board
04/07/18 download Created with Sketch. 169.94KB
NTI Final Director's Interest Notice
28/06/18 download Created with Sketch. 185.93KB
NTI Board Change
28/06/18 download Created with Sketch. 161.94KB
NTI Change in substantial holding
27/06/18 download Created with Sketch. 145.62KB
NTI Clinical Trial Publication Provisionally Accepted
25/06/18 download Created with Sketch. 333.85KB
NTI Mente Autism Approval From Italcert
04/06/18PRICE SENSITIVE download Created with Sketch. 169.99KB
NTI Appendix 3B
14/05/18 download Created with Sketch. 249.25KB
NTI Quarterly Report and Appendix 4C
30/04/18PRICE SENSITIVE download Created with Sketch. 370.77KB
NTI Appendix 4D and 31 December 2017 Half Year Financial Report
28/02/18PRICE SENSITIVE download Created with Sketch. 439.78KB
NTI Amendment to December 2017 Quarterly Report
05/02/18 download Created with Sketch. 777.66KB
NTI Quarterly Report and Appendix 4C
30/01/18PRICE SENSITIVE download Created with Sketch. 783.6KB
NTI Change in substantial holding
22/01/18 download Created with Sketch. 129.76KB
NTI Indian Distribution Agreement
18/01/18PRICE SENSITIVE download Created with Sketch. 582.09KB
NTI Clarification Statement
10/01/18 download Created with Sketch. 572.86KB
NTI Becoming a substantial holder
10/01/18 download Created with Sketch. 146.57KB
NTI Clinical Trial Update
08/01/18 download Created with Sketch. 593.49KB
NTI Change of Directors Interest Notice
30/11/17 download Created with Sketch. 364.02KB
NTI Change of Directors Interest Notice
30/11/17 download Created with Sketch. 363.65KB
NTI Appendix 3B
30/11/17 download Created with Sketch. 704.07KB
NTI Design Agreement with eemagine
27/11/17PRICE SENSITIVE download Created with Sketch. 578.27KB
NTI 2017 AGM Results
23/11/17 download Created with Sketch. 374.75KB
NTI AGM Presentation
23/11/17 download Created with Sketch. 1.95MB
NTI Investor Call
09/11/17 download Created with Sketch. 583.01KB
NTI Quarterly Report and Appendix 4C
31/10/17PRICE SENSITIVE download Created with Sketch. 906.16KB
NTI Announcement Correction
25/10/17 download Created with Sketch. 476.75KB
NTI Appendix 3B
25/10/17 download Created with Sketch. 688.97KB
NTI Allotment of Placement Shares
25/10/17 download Created with Sketch. 483.42KB
NTI Notice of Meeting - Despatch
23/10/17 download Created with Sketch. 1.56MB
NTI Reinstatement to Official Quotation
16/10/17PRICE SENSITIVE download Created with Sketch. 251.67KB
NTI Capital Raising Completed
16/10/17PRICE SENSITIVE download Created with Sketch. 595.56KB
NTI Suspension from Official Quotation
12/10/17PRICE SENSITIVE download Created with Sketch. 559.91KB
NTI Trading Halt
11/10/17PRICE SENSITIVE download Created with Sketch. 764.02KB
NTI Neurotech Investor Presentation
04/10/17 download Created with Sketch. 3.03MB
NTI Response to ASX Query
03/10/17PRICE SENSITIVE download Created with Sketch. 916.91KB
NTI Neurotech Presentations
28/09/17 download Created with Sketch. 596.79KB
NTI Clinical Trial Preliminary Outcomes
27/09/17PRICE SENSITIVE download Created with Sketch. 619.33KB
NTI Trading Halt
25/09/17PRICE SENSITIVE download Created with Sketch. 531.65KB
NTI Distributor Update
14/09/17PRICE SENSITIVE download Created with Sketch. 604.91KB
NTI Corporate Governance Statement
06/09/17 download Created with Sketch. 379.16KB
NTI Appendix 4E
01/09/17PRICE SENSITIVE download Created with Sketch. 365.03KB
NTI Annual Report to shareholders
31/08/17 download Created with Sketch. 955.11KB
NTI Appendix 4G
31/08/17 download Created with Sketch. 378.22KB
NTI Italian Distributor Update
21/08/17PRICE SENSITIVE download Created with Sketch. 476.74KB
NTI Quarterly Report and Appendix 4C
31/07/17PRICE SENSITIVE download Created with Sketch. 794.83KB
NTI Neurotech completes Turkey shipment
10/07/17PRICE SENSITIVE download Created with Sketch. 638.08KB
NTI Neurotech renews Turkey distribution agreement
26/06/17PRICE SENSITIVE
NTI Distribution Update
19/06/17PRICE SENSITIVE download Created with Sketch. 498.83KB
NTI 2017 European Neuro Convention Presentation
08/06/17 download Created with Sketch. 2.61MB
NTI Mente Autism Update
05/06/17PRICE SENSITIVE download Created with Sketch. 600.32KB
NTI US Clinical Trial Update
29/05/17PRICE SENSITIVE download Created with Sketch. 591.33KB
NTI First Shipment to Greece
25/05/17PRICE SENSITIVE download Created with Sketch. 600.17KB
NTI Distribution Update
22/05/17PRICE SENSITIVE download Created with Sketch. 583.41KB
NTI Appendix 3B and Release of Restricted Securities from Escrow
15/05/17 download Created with Sketch. 268.43KB
NTI FDA Update
12/05/17PRICE SENSITIVE download Created with Sketch. 475.69KB
NTI Quarterly Reports
26/04/17PRICE SENSITIVE download Created with Sketch. 2.78MB
NTI Distribution Partner Update
26/04/17PRICE SENSITIVE download Created with Sketch. 477.23KB
NTI Release of 699,000 Shares from Escrow
21/04/17 download Created with Sketch. 342.03KB
NTI FDA Pre submission and World Autism Awareness Day
30/03/17PRICE SENSITIVE download Created with Sketch. 490.57KB
NTI US Clinical Trial Update
29/03/17PRICE SENSITIVE download Created with Sketch. 483KB
NTI Mente Pro Update
09/03/17PRICE SENSITIVE download Created with Sketch. 597.39KB
NTI Austrian Distribution Partner
02/03/17PRICE SENSITIVE download Created with Sketch. 480.5KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
1.4¢
Change
0.001(7.69%)
Mkt cap ! $14.69M
Open High Low Value Volume
1.3¢ 1.4¢ 1.3¢ $4.026K 307.2K

Buyers (Bids)

No. Vol. Price($)
1 1917576 1.3¢
 

Sellers (Offers)

Price($) Vol. No.
1.4¢ 505017 5
View Market Depth
Last trade - 16.10pm 29/08/2025 (20 minute delay) ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.